Bixiye
P42-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 571 - 580 ee natiijooyinka 3607
Bixiye
P37-24 Residential Treatment Claims for Minnesota Health Care Programs
Taariikhda wax ku ool ah ee barnaamijka: Jun 03, 2024
Bixiye
Atypical Antipsychotics - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Atypical Antipsychotics - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
QP44-24 MHCP Pharmacy Benefit Exclusion for Anktiva® and Docivyx™
Taariikhda uu dhaqangalayo Barnaamijka: May 22, 2024
Bixiye
QP38-24 Training Webinars for New Prior Authorization Submission Process
Taariikhda uu dhaqangalayo Barnaamijka: May 22, 2024
Bixiye
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024